Correspondence 0001493152-23-024371 from Galmed Pharmaceuticals Ltd. (GLMD)
Galmed Pharmaceuticals Ltd.
Date: July 12, 2023 · CIK: 0001595353 · Accession: 0001493152-23-024371
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-272722
Letter
Re: Galmed Pharmaceuticals Ltd.
July 12, 2023
VIA EDGAR
Division of Corporation Finance
U.S. Securities and Exchange Commission
F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form F-1
Filed July 12, 2023
File No. 333-272722
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Maxim Group LLC, as placement agent, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 9:00 a.m., Washington D.C. time, on Thursday, July 13, 2023, or as soon thereafter as may be practicable.
Pursuant to Rule 460 of the General Rules and Regulations under the Act, the undersigned advises that copies of the Preliminary Prospectus dated July 12, 2023 have been distributed to prospective dealers, institutional investors, retail investors and others.
The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
Maxim Group LLC
Show Raw Text
CORRESP
1
filename1.htm
July
12, 2023
VIA
EDGAR
Division
of Corporation Finance
U.S.
Securities and Exchange Commission
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Galmed
Pharmaceuticals Ltd.
Registration
Statement on Form F-1
Filed
July 12, 2023
File
No. 333-272722
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as
amended, Maxim Group LLC, as placement agent, hereby requests acceleration of the effective date of the above-referenced Registration
Statement so that it will become effective at 9:00 a.m., Washington D.C. time, on Thursday, July 13, 2023, or as soon thereafter as may
be practicable.
Pursuant
to Rule 460 of the General Rules and Regulations under the Act, the undersigned advises that copies of the Preliminary Prospectus dated
July 12, 2023 have been distributed to prospective dealers, institutional investors, retail investors and others.
The
undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as
amended.
Very truly yours,
Maxim Group LLC
By:
/s/ Clifford A. Teller
Name:
Clifford A. Teller
Title:
Co-President